Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Prevention and infection control of HIV infection and AIDS

Chin B

Background: Although the global incidence of human immunodeficiency virus (HIV) has decreased significantly since modern antiretroviral therapy (ART), new HIV infections steadily occur, in the Republic of Korea. Based on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Human Mpox with Isolated Perianal Ulcers Development in Convalescent Phase

Yim HS, Um J, Kim HS, Jeon J, Kim JS, Choi JP, Kim MK, Kim Y, Park JS, Chin B

A 35-year-old man who returned from Germany developed fever, generalized pain, severe anal pain, and generalized skin rash, confirmed to be monkeypox (mpox). While he was previously confirmed to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea

Jeon J, Chin B

The coronavirus disease 2019 (COVID-19) continues to threaten public health in Korea although several surges have passed in the past 3 years since 2019. Although patients with mild-to-moderate COVID-19 can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea

Lim DH, Jeong JY, Nam S, Choi J, Kwon HC, Yoon YB, Kim Y, Chin B

Background: Because of the very low incidence of human immunodeficiency virus (HIV) coinfection in Korea, data on hepatitis C virus (HCV)/HIV coinfection are limited. This study aimed to investigate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea

Kwak MY, Jo EY, Chin B, Park SE, Yim J, Lee JE, Jo KE, Kim YS, Lee JE, Yoon YK, Seo YB, Jeong SJ, Kang YM, Joo EJ, Yoon JH, Kim SB, Kim GY, Kim MK

Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients’ care, difficulty incorporating evolving COVID-19...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of Human Immunodeficiency Virus Care Continuum in Korea using the National Health Insurance System Data

Cho YM, Chin B

Background: Antiretroviral therapy (ART) has been shown to significantly reduce the likelihood of transmission to other people as well as promoting the health of people living with Human immunodeficiency virus/acquired...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changing Features of Liver Injury in COVID-19 Patients: Impact of Infection with the SARS-CoV-2 Delta (B.1.617.2) Variants

Choi CW, Sung HK, Jeong JY, Lim DH, Choi J, Kwon HC, Nam S, Kim Y, Chin B

Background: There is growing evidence that abnormal liver function tests (LFTs) are common in patients with coronavirus disease 2019 (COVID-19). However, it is not known whether viral involvement in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019

Seok H, Park DW, Kim KN, Kim MJ, Kim SH, Kim JY, Park SE, Park SY, Eun BW, Lee MS, Chang HH, Jung H, Jeong HW, Jo SN, Chin B, Choi YH, Choi EH, Choi HJ, Jee Y, Kim YS

During the 2019 domestic measles outbreak in Korea, measles occurred in healthcare workers with two doses of the measles, mumps and rubella vaccine, and the strict application of the Occupational...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients

Kim MK, Lee KS, Ham SY, Choi YY, Lee E, Lee S, Lee B, Jeon J, Chin B, Kim Y, Kim G, Jang HC, Choi JP, Park SW

Background Nirmatrelvir-ritonavir is highly effective in preventing severe coronavirus disease 2019 (COVID-19) in high-risk patients with mild-to-moderate severity. However, real-world performance data are limited, and the drug is not so acceptable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr